Head and Neck Cancer

HEAD AND NECK CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Biosimilars in Cancer Care: Insights From 2020 and Expectations for 2021

Sean McGowan, senior director of Biosimilars at AmerisourceBergen, and Brian Ansay, senior vice president of Sales and Corporate Services at ION Solutions, review 2020 biosimilar trends in oncology and forecast what is ahead in 2021.
NCI-MATCH Trial Identifies Actionable Alterations in More Than One-Third of Patients With Cancer

Researchers have identified actionable alterations in nearly 38% of patients with cancer, and almost 18% of patients were assigned to treatments based on their molecular profiling results.
Targeted Therapies, Immunotherapies, Immunomodulators: A Quick Guide to Cancer Therapy Descriptions

Sometimes the distinctions between cancer treatment groups are a little blurry. Here’s a guide to their definitions and origins.
Reliability of Laboratory-Developed Tests Called Into Question

A recent HHS announcement spurred concern that FDA oversight of LDTs was eroding, threatening patient safety — but the reality is less dire.
The Twitter Effect on How Oncologists Conduct and Share Research

The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.

HEAD AND NECK CANCER NEWS

Head and Neck Cancer

Factors Identified for Poor Long-Term Survival in RT-Treated Patients With Oropharyngeal Cancer

January 5, 2021

Overall, it is estimated that approximately 7% to 11% of patients experience tumor shrinkage in phase 1 trials.

Statistical Index Suggests That Many ICI Trials Show Uncertain Clinical Benefit

November 5, 2020

Experts Establish Surgical Priority Ranking for Head and Neck Cancers

September 10, 2020

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis.

Transoral Robotic Surgery Ups Survival in Oropharyngeal Cancer

August 25, 2020

Evaluating a patient's weight loss.

Weight and Swallowing-Related Quality of Life in Patients Treated for Oropharyngeal Cancer

August 21, 2020

Next post in Head and Neck Cancer

Experts Establish Surgical Priority Ranking for Head and Neck Cancers